RenovoRx, Inc.
RNXTNASDAQHealthcare● Active
$0.89
+$0.01(+1.56%)
Market Cap$32966460
P/E Ratio—
52W High$1.45
52W Low$0.701
RenovoRx, Inc.（RNXT）· 损益表
年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q（经 FMP 聚合）· 可在下方切换周期与 M/B/T 单位。
FMP · RNXT · 截至 2026-06-09
财务报表
Revenue · Gross Profit · Net Income
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $1.12M | $0.04M | $0.00M | $0.00M | $0.00M |
| Cost of Revenue | $0.33M | $0.00M | $0.00M | $0.00M | $0.00M |
| Gross Profit | $0.80M | $0.04M | $0.00M | $0.00M | $0.00M |
| Gross Margin %(computed) | 70.88% | 100.00% | — | — | — |
| Operating Expenses | |||||
| R&D Expenses | $6.27M | $6.03M | $5.67M | $4.30M | $3.04M |
| G&A Expenses | $7.04M | $4.99M | $5.73M | $5.65M | $2.63M |
| Total Operating Expenses | $13.31M | $11.01M | $11.40M | $9.95M | $5.67M |
| Operating Income | ($12.51M) | ($10.97M) | ($11.40M) | ($9.95M) | ($5.67M) |
| Operating Margin %(computed) | — | — | — | — | — |
| Interest Income | $0.43M | $0.38M | $0.00M | $0.06M | $0.00M |
| Interest Expense | $0.00M | $0.00M | $0.11M | $0.06M | $0.83M |
| Income Before Tax | ($11.17M) | ($8.81M) | ($10.23M) | ($9.89M) | ($6.32M) |
| Income Tax Expense | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Net Income | ($11.17M) | ($8.81M) | ($10.23M) | ($9.89M) | ($6.32M) |
| Net Margin %(computed) | -994.48% | — | — | — | — |
| Per Share & EBITDA | |||||
| EPS (Basic) | $-0.32 | $-0.37 | $-0.50 | $-0.54 | $-0.40 |
| Wtd Avg Shares | 35.33M | 23.61M | 20.58M | 18.10M | 17.87M |
| EBITDA | ($12.51M) | ($10.97M) | ($11.39M) | ($9.94M) | ($5.48M) |
| EBITDA Margin %(computed) | — | — | — | — | — |
数据来源：Financial Modeling Prep · 最后更新：2026-06-09 · USD · M
深入了解RenovoRx, Inc.
关于RenovoRx, Inc.（RNXT）损益表
RenovoRx, Inc.（RNXT）损益表数据来源于SEC Form 10-K及10-Q申报文件。2025财年，RNXT实现营收$0.00B，毛利润$0.00B（毛利率70.88%），净利润($0.01B)（净利率-994.48%）。
常见问题
RNXT · 4 问RenovoRx, Inc.（RNXT）2025财年营收为$0.00B，同比up2511.6%。
RNXT revenueRNXT salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-09